Literature DB >> 34143713

Identification of Missense Extracellular Matrix Gene Variants in a Large Glaucoma Pedigree and Investigation of the N700S Thrombospondin-1 Variant in Normal and Glaucomatous Trabecular Meshwork Cells.

Mary K Wirtz1, Renee Sykes1, John Samples2, Beth Edmunds1, Dongseok Choi1,3,4, Douglas R Keene5, Sara F Tufa5, Ying Ying Sun1, Kate E Keller1,6.   

Abstract

PURPOSE: Primary open-angle glaucoma (POAG) is a complex heterogeneous disease. While several POAG genes have been identified, a high proportion of estimated heritability remains unexplained. Elevated intraocular pressure (IOP) is a leading POAG risk factor and dysfunctional extracellular matrix (ECM) in the trabecular meshwork (TM) contributes to elevated IOP. In this study, we sought to identify missense variants in ECM genes that correlate with ocular hypertensive POAG.
METHODS: Whole-genome sequencing was used to identify genetic variants in five members of a large POAG family (n = 68) with elevated IOP. The remaining family members were screened by Sanger sequencing. Unrelated normal (NTM) and glaucomatous (GTM) cells were sequenced for the identified variants. The ECM protein levels were determined by Western immunoblotting and confocal and electron microscopy investigated ECM ultrastructural organization.
RESULTS: Three ECM gene variants were significantly associated with POAG or elevated IOP in a large POAG pedigree. These included rs2228262 (N700S; thrombospondin-1 (THBS1, TSP1)), rs112913396 (D563 G; collagen type VI, alpha 3 (COL6A3)) and rs34759087 (E987K; laminin subunit beta 2 (LAMB2)). Screening of unrelated TM cells (n = 27) showed higher prevalence of the THBS1 variant but not the LAMB2 variant, in GTM cells (39%) than NTM cells (11%). The rare COL6A3 variant was not detected. TSP1 protein was upregulated and COL6A3 was down-regulated in TM cells with N700S subject to mechanical stretch, an in vitro method that mimics elevated IOP. Immunofluorescence showed increased TSP1 immunostaining in cell strains with N700S compared to wild-type TM cells. Ultrastructural studies showed ECM disorganization and altered collagen type VI distribution in GTM versus NTM cells.
CONCLUSIONS: Our results suggest that missense variants in ECM genes may not cause catastrophic changes to the TM, but over many years, subtle changes in ECM may accumulate and cause structural disorganization of the outflow resistance leading to elevated IOP in POAG patients.

Entities:  

Keywords:  extracellular matrix; genetics; glaucoma; trabecular meshwork

Mesh:

Substances:

Year:  2021        PMID: 34143713      PMCID: PMC8733052          DOI: 10.1080/02713683.2021.1945109

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.555


  74 in total

1.  Adult-onset primary open-angle glaucoma caused by mutations in optineurin.

Authors:  Tayebeh Rezaie; Anne Child; Roger Hitchings; Glen Brice; Lauri Miller; Miguel Coca-Prados; Elise Héon; Theodore Krupin; Robert Ritch; Donald Kreutzer; R Pitts Crick; Mansoor Sarfarazi
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

2.  Collagen-related genes influence the glaucoma risk factor, central corneal thickness.

Authors:  Eranga N Vithana; Tin Aung; Chiea Chuen Khor; Belinda K Cornes; Wan-Ting Tay; Xueling Sim; Raghavan Lavanya; Renyi Wu; Yingfeng Zheng; Martin L Hibberd; Kee Seng Chia; Mark Seielstad; Liang Kee Goh; Seang-Mei Saw; E Shyong Tai; Tien Y Wong
Journal:  Hum Mol Genet       Date:  2010-11-23       Impact factor: 6.150

3.  Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures.

Authors:  Ramez I Haddadin; Dong-Jin Oh; Min Hyung Kang; Guadalupe Villarreal; Ja-Heon Kang; Rui Jin; Haiyan Gong; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-28       Impact factor: 4.799

4.  From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.

Authors:  Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo
Journal:  Curr Protoc Bioinformatics       Date:  2013

Review 5.  Primary open-angle glaucoma.

Authors:  Young H Kwon; John H Fingert; Markus H Kuehn; Wallace L M Alward
Journal:  N Engl J Med       Date:  2009-03-12       Impact factor: 91.245

Review 6.  Update on the genetics of primary open-angle glaucoma.

Authors:  Hannah Youngblood; Michael A Hauser; Yutao Liu
Journal:  Exp Eye Res       Date:  2019-09-13       Impact factor: 3.467

Review 7.  The extracellular matrix: Tools and insights for the "omics" era.

Authors:  Alexandra Naba; Karl R Clauser; Huiming Ding; Charles A Whittaker; Steven A Carr; Richard O Hynes
Journal:  Matrix Biol       Date:  2015-07-08       Impact factor: 11.583

Review 8.  Consensus recommendations for trabecular meshwork cell isolation, characterization and culture.

Authors:  Kate E Keller; Sanjoy K Bhattacharya; Theresa Borrás; Thomas M Brunner; Sunee Chansangpetch; Abbott F Clark; W Michael Dismuke; Yiqin Du; Michael H Elliott; C Ross Ethier; Jennifer A Faralli; Thomas F Freddo; Rudolf Fuchshofer; Michael Giovingo; Haiyan Gong; Pedro Gonzalez; Alex Huang; Murray A Johnstone; Paul L Kaufman; Mary J Kelley; Paul A Knepper; Casey C Kopczynski; John G Kuchtey; Rachel W Kuchtey; Markus H Kuehn; Raquel L Lieberman; Shan C Lin; Paloma Liton; Yutao Liu; Elke Lütjen-Drecoll; Weiming Mao; Marisse Masis-Solano; Fiona McDonnell; Colleen M McDowell; Darryl R Overby; Padmanabhan P Pattabiraman; Vijay K Raghunathan; P Vasanth Rao; Douglas J Rhee; Uttio Roy Chowdhury; Paul Russell; John R Samples; Donald Schwartz; Evan B Stubbs; Ernst R Tamm; James C Tan; Carol B Toris; Karen Y Torrejon; Janice A Vranka; Mary K Wirtz; Thomas Yorio; Jie Zhang; Gulab S Zode; Michael P Fautsch; Donna M Peters; Ted S Acott; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2018-03-09       Impact factor: 3.770

9.  Three-dimensional architecture of collagen type VI in the human trabecular meshwork.

Authors:  Elena Koudouna; Robert D Young; Morio Ueno; Shigeru Kinoshita; Andrew J Quantock; Carlo Knupp
Journal:  Mol Vis       Date:  2014-05-13       Impact factor: 2.367

10.  Myosin-X Silencing in the Trabecular Meshwork Suggests a Role for Tunneling Nanotubes in Outflow Regulation.

Authors:  Ying Ying Sun; Yong-Feng Yang; Kate E Keller
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-01       Impact factor: 4.799

View more
  5 in total

1.  EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.

Authors:  Edward Ryan A Collantes; Manuel S Delfin; Baojian Fan; Justine May R Torregosa; Christine Siguan-Bell; Nilo Vincent de Guzman Florcruz; Jose Maria D Martinez; Barbara Joy Masna-Hidalgo; Vincent Paul T Guzman; Jewel Faith Anotado-Flores; Faye D Levina; Sophia Raine C Hernandez; Anthony A Collantes; Michael Carreon Sibulo; Shisong Rong; Janey L Wiggs
Journal:  Hum Mutat       Date:  2021-12-28       Impact factor: 4.878

Review 2.  Thrombospondin-1 Signaling Through the Calreticulin/LDL Receptor Related Protein 1 Axis: Functions and Possible Roles in Glaucoma.

Authors:  Joanne E Murphy-Ullrich
Journal:  Front Cell Dev Biol       Date:  2022-05-27

Review 3.  Pathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork-A review.

Authors:  Kate E Keller; Donna M Peters
Journal:  Clin Exp Ophthalmol       Date:  2022-01-17       Impact factor: 4.383

4.  The Effects of Mechanical Stretch on Integrins and Filopodial-Associated Proteins in Normal and Glaucomatous Trabecular Meshwork Cells.

Authors:  Yong-Feng Yang; Ying Ying Sun; Donna M Peters; Kate E Keller
Journal:  Front Cell Dev Biol       Date:  2022-04-29

5.  Effect of SPARC Suppression in Mice, Perfused Human Anterior Segments, and Trabecular Meshwork Cells.

Authors:  William W MacDonald; Swarup S Swaminathan; Jae Young Heo; Alexandra Castillejos; Jessica Hsueh; Brian J Liu; Diane Jo; Annie Du; Hyunpil Lee; Min Hyung Kang; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.